Target intelligence / Profile preview

Glyceraldehyde-3-phosphate dehydrogenase pseudogene 62 (GAPDHP62)

Target
GAPDHP62
Molecular classification
Other (Pseudogene)
01

Overview

Glyceraldehyde-3-phosphate dehydrogenase pseudogene 62 is a non-functional segment of DNA in the human genome that resembles the active glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH), a well-characterized enzyme central to glycolysis. Pseudogenes such as GAPDHP62 arise through gene duplication or retrotransposition, but accumulate disabling mutations and are not translated into functional proteins. The existence of GAPDH pseudogenes may complicate molecular assays like quantitative PCR, but GAPDHP62 itself does not encode a functional protein, is not considered a receptor, enzyme, or therapeutic target, and has no known direct biological or clinical significance. Summary of issues: - The entity is a pseudogene, not a protein-coding gene. - It does not serve as a canonical therapeutic target or receptor. - There are no drugs or mechanisms of action associated with this pseudogene. - Existing literature typically refers to the functional GAPDH gene, not its pseudogenes, when discussing enzymes or therapeutic targets. Note: GAPDHP62 is only relevant in genomic studies, where it may impact the interpretation of results if pseudogenes are not differentiated from functional genes.

Other names
GAPDHL7GAPDL7GAPDHP62Glyceraldehyde-3-phosphate dehydrogenase-like 7, pseudogene
02

Mechanism of action

Not applicable

03

Biological functions

None (pseudogenes do not exert biological function via encoded protein)
04

Disease associations

Other (pseudogenes, including GAPDH pseudogenes, are generally not directly implicated in disease, but they can interfere with gene quantification in molecular biology assays)

Beyond the preview

Go deeper on Glyceraldehyde-3-phosphate dehydrogenase pseudogene 62 (GAPDHP62).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glyceraldehyde-3-phosphate dehydrogenase pseudogene 62 (GAPDHP62).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call